.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Moodys
Colorcon
Deloitte
Baxter
Cerilliant
Mallinckrodt
Citi
Harvard Business School

Generated: June 29, 2017

DrugPatentWatch Database Preview

URECHOLINE Drug Profile

« Back to Dashboard

What is the patent landscape for Urecholine, and what generic Urecholine alternatives are available?

Urecholine is a drug marketed by Odyssey Pharms and is included in five NDAs.

The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.

Summary for Tradename: URECHOLINE

Patents:0
Applicants:1
NDAs:5
Suppliers / Packagers: see list2
Bulk Api Vendors: see list56
Clinical Trials: see list1
Patent Applications: see list645
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:URECHOLINE at DailyMed

Pharmacology for Tradename: URECHOLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms
URECHOLINE
bethanechol chloride
INJECTABLE;INJECTION006536-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Odyssey Pharms
URECHOLINE
bethanechol chloride
TABLET;ORAL088441-001May 29, 1984AARXNoYes► Subscribe► Subscribe
Odyssey Pharms
URECHOLINE
bethanechol chloride
TABLET;ORAL006536-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Odyssey Pharms
URECHOLINE
bethanechol chloride
TABLET;ORAL089095-001Dec 19, 1985AARXNoYes► Subscribe► Subscribe
Odyssey Pharms
URECHOLINE
bethanechol chloride
TABLET;ORAL006536-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Accenture
Harvard Business School
Argus Health
Daiichi Sankyo
Express Scripts
Moodys
Johnson and Johnson
Teva
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot